Sugi Predict

Sugi Predict / Compounds / SCHEMBL170289

SCHEMBL170289

SCHEMBL170289

C[N+]1(CC(=O)O)CCCC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BBOX1 O75936 2/20 0.56
▸ CTDSP1 Q9GZU7 3/20 0.48
▸ TSHR P16473 2/20 0.48
▸ HTT P42858 2/20 0.46
▸ LMNA P02545 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ APOBEC3A P31941 6/20 0.40
▸ APOBEC3G Q9HC16 6/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TP53 P04637 1/20 0.37
▸ PABPC1 P11940 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5087967 0.97 BBOX1 (0.54) BBOX1CTDSP1TSHRHTTLMNA
Hydrochloric Acid SCHEMBL5088036 0.97 BBOX1 (0.54) BBOX1CTDSP1TSHRHTTLMNA
Hydrochloric Acid SCHEMBL5085268 0.95 BBOX1 (0.52) BBOX1CTDSP1TSHRHTTLMNA
SCHEMBL13051491 0.82 BBOX1 (0.39) BBOX1CTDSP1TSHRHTTKDM4E
SCHEMBL13627429 0.81 BBOX1 (0.48) BBOX1CTDSP1TSHRHTTLMNA
SCHEMBL13627229 0.80 BBOX1 (0.47) BBOX1CTDSP1TSHRHTTLMNA
SCHEMBL439766 0.78 PABPC1 (0.46) BBOX1CTDSP1APOBEC3AAPOBEC3GALDH1A1
SCHEMBL7037472 0.77 CTDSP1 (0.47) BBOX1CTDSP1TSHRHTTLMNA
SCHEMBL3172717 0.77 CTDSP1 (0.47) BBOX1CTDSP1TSHRHTTLMNA
Hydrochloric Acid SCHEMBL9193743 0.77 CTDSP1 (0.52) BBOX1CTDSP1TSHRHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119920847-A Pole piece, preparation method thereof, diaphragm-free battery and solid-state battery 重庆太蓝新能源有限公司 2025-05-02 — — CN claimed
WO-2017044411-A1 METHODS AND COMPOSITIONS FOR SOFT ANTICHOLINERGIC ZWITTERIONS BODOR LABORATORIES, INC. (US) 2017-03-16 — — WO claimed
WO-2017040307-A1 USE OF SELECTED ANTICHOLINERGIC ZWITTERIONS BODOR LABORATORIES, INC. (US) 2017-03-09 — — WO claimed
US-12584190-B2 Methods for selective recovery of rare earth elements and metals from coal ash by ionic liquids GEORGIA TECH RESEARCH CORPORATION (US) 2026-03-24 — — US disclosed
CN-119920847-A Pole piece, preparation method thereof, diaphragm-free battery and solid-state battery 重庆太蓝新能源有限公司 2025-05-02 — — CN disclosed
CN-119890422-A Electrolyte membrane for a battery for circulating lithium ions and method for manufacturing same 通用汽车环球科技运作有限责任公司 2025-04-25 — — CN disclosed
US-20230357886-A1 Methods for Selective Recovery of Rare Earth Elements and Metals from Coal Ash by Ionic Liquids GEORGIA TECH RESEARCH CORPORATION 2023-11-09 — — US disclosed
EP-4077748-A1 METHODS FOR SELECTIVE RECOVERY OF RARE EARTH ELEMENTS AND METALS FROM COAL ASH BY IONIC LIQUIDS Georgia Tech Research Corporation (US) 2022-10-26 — — EP disclosed
US-10550108-B2 Poly(ADP-ribose) polymerase 1 inhibitors structurally unrelated to NAD INSTITUTE FOR CANCER RESEARCH (US) 2020-02-04 — — US disclosed
EP-3478365-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF COPD Bodor Laboratories, Inc. (US) 2019-05-08 — — EP disclosed
WO-2018006001-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF COPD BODOR LABORATORIES, INC. (US) 2018-01-04 — — WO disclosed
US-20090233222-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR FUJIFILM CORPORATION (JP) 2009-09-17 — — US disclosed
US-7419934-B2 Reversible thermosensitive coloring material and reversible thermosensitive recording material using the reversible thermosensitive coloring material RICOH COMPANY LIMITED (JP) 2008-09-02 — — US disclosed
EP-1957451-A1 SOFT ANTICHOLINERGIC ZWITTERIONS Bodor, Nicholas S. (US) 2008-08-20 — — EP disclosed
WO-2007147222-A9 NOVEL IONIC LIQUIDS UNIV LEUVEN KATH (BE) 2008-02-14 — — WO disclosed
WO-2007147222-A9 NOVEL IONIC LIQUIDS UNIV LEUVEN KATH (BE) 2008-02-14 — — WO disclosed
WO-2007147222-A2 NOVEL IONIC LIQUIDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2007-12-27 — — WO disclosed
WO-2007147222-A2 NOVEL IONIC LIQUIDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2007-12-27 — — WO disclosed
US-20070259782-A1 REVERSIBLE THERMOSENSITIVE COLORING MATERIAL AND REVERSIBLE THERMOSENSITIVE RECORDING MATERIAL USING THE REVERSIBLE THERMOSENSITIVE COLORING MATERIAL RICOH COMPANY, LIMITED (JP) 2007-11-08 — — US disclosed
WO-2007059021-A1 SOFT ANTICHOLINERGIC ZWITTERIONS BODOR NICHOLAS S (US) 2007-05-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12584190-B2 Methods for selective recovery of rare earth elements and metals from coal ash by ionic liquids CA2, ASH2L, CA1 BBOX1 4883/4885CTDSP1 1113/4885TSHR 3483/4885
US-10550108-B2 Poly(ADP-ribose) polymerase 1 inhibitors structurally unrelated to NAD PARP1, PARP11, PARP14 BBOX1 1255/4885CTDSP1 242/4885TSHR 4419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.